AKT2 and ovarian carcinoma: The same study showed a more prominent increase of apoptosis (5.5-fold) and decrease of proliferation (51%) following knockdown of AKT2 in the OVCAR8 cell line, known to have a copy-gain of AKT2, compared to the other ovarian cancer lines tested.